GlassScriptPhysician profile
Ramon Sanchez-Rauder
NPI 1750547162
$460.81
in general payments reported to CMS, 2019-2025
13 companies · $20.57 in 2025
The $20.57 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.29 · 2020: $23.54 · 2021: $129 · 2022: $150 · 2023: $33.36 · 2024: $59.90 · 2025: $20.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $94.56 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $94.56 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $84.76 | 2019-2022 | |
| Hologic Sales and Service, LLC | $72.87 | 2022-2024 | Myosure Tissue Removal Device, Omni Hysteroscope |
| Myovant Sciences INC. | $71.37 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.74 | 2022-2025 | |
| Astellas Pharma US INC | $41.06 | 2022-2024 | Veozah |
| Pfizer INC. | $40.97 | 2022-2023 | |
| Scynexis, INC. | $15.94 | 2021 | |
| Sumitomo Pharma America, INC. | $14.09 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $13.95 | 2019 | |
| Shield Therapeutics INC | $13.78 | 2022 | |
| Duchesnay USA Incorporated | $12.76 | 2019 | |
| Avion Pharmaceuticals | $12.45 | 2022 | |
| Millicent US INC | $11.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Sanchez-Rauder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.